Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke
Pharm Stat
.
2019 Mar;18(2):140-144.
doi: 10.1002/pst.1935.
Authors
Robert Hemmings
1
,
Armin Koch
2
Affiliations
1
Medicines and Healthcare Products Regulatory Agency, London, UK.
2
Institut fur Biometrie, Medizinische Hochschule Hannover, Hannover, Germany.
PMID:
30900391
PMCID:
PMC6593771
DOI:
10.1002/pst.1935
No abstract available
Publication types
Comment
MeSH terms
Data Interpretation, Statistical
Research Design*